Trials / Completed
CompletedNCT04431843
the Efficacy and Safety of Spirulina Maxima Extract on Improvement of Cognitive Function
A 12 Weeks, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Spirulina Maxima Extract on Improvement of Cognitive Function
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Chonbuk National University Hospital · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Accepted
Summary
This study was the evaluate the efficacy and safety of Spirulina maxima extract on the improvement of Cognitive Function
Detailed description
This study was 12 weeks, randomized, double-blind, placebo-controlled human trial to evaluate. 80 subjects participated in Spirulina maxima extract or placebo group. To evaluate the changes in the evaluation items when Spirulina maxima extract was taken 12 weeks compared with placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Spirulina maxima extract | once a day for 2 p.o., after breakfast and dinner(1.52 g/day, Spirulina maxima extract for 1.5 g/day) for 12 week |
| DIETARY_SUPPLEMENT | Placebo | once a day for 2 p.o., after breakfast and dinner(1.52 g/day, Spirulina maxima extract for 0 g/day) for 12 week |
Timeline
- Start date
- 2020-03-17
- Primary completion
- 2020-11-26
- Completion
- 2020-11-26
- First posted
- 2020-06-16
- Last updated
- 2023-02-10
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04431843. Inclusion in this directory is not an endorsement.